Adrienne Farid
Directeur des opérations chez CENTURY THERAPEUTICS, INC.
Fortune : 407 591 $ au 31/05/2024
Profil
Adrienne Farid is currently the Chief Operations Officer at Century Therapeutics, Inc. She previously worked as a Director at Carisma Therapeutics, Inc. and held the position of VP-Project Leadership at Celgene Corp.
from 2014 to 2017.
Prior to that, she served as the Global Head-Project & Portfolio Management at Roche Pharmaceuticals, Inc. from 1995 to 2011.
Dr. Farid holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/05/2024 | 137 236 ( 0,16% ) | 407 591 $ | 31/05/2024 |
Postes actifs de Adrienne Farid
| Sociétés | Poste | Début |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Directeur des opérations | 01/04/2021 |
Anciens postes connus de Adrienne Farid
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/07/2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/2011 |
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Adrienne Farid
| Barnard College | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CENTURY THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
